Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy? Analysis of data from a noninterventional study of rheumatoid arthritis patients initiating treatment with adalimumab

Most studies of methotrexate (MTX) in combination with tumor necrosis factor (TNF) inhibitors have focused on treatment-naive patients with early disease. The goal of this study was to evaluate whether previous biologic therapy influenced the impact of concomitant MTX in patients initiating treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmalzing, Marc, Behrens, Frank, Schwaneck, Eva C., Koehm, Michaela, Greger, Gerd, Gnann, Holger, Burkhardt, Harald, Tony, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220320/
https://www.ncbi.nlm.nih.gov/pubmed/32384515
http://dx.doi.org/10.1097/MD.0000000000020201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220320/
https://www.ncbi.nlm.nih.gov/pubmed/32384515
http://dx.doi.org/10.1097/MD.0000000000020201

Ejemplares similares